CorTec

CorTec GmbH, founded in 2010 and based in Freiburg, Germany, is a medical technology company focused on implantable neurotechnology and active implantable systems, including brain-computer interface (BCI) devices. The company aims to enable communication with the brain to address neurological diseases, particularly through its Brain Interchange System, which is designed for stroke rehabilitation. CorTec provides a wide range of services related to the design, development, and manufacturing of implantable neurotechnological devices and components. Their expertise covers the entire medical device lifecycle, from concept and engineering to regulatory compliance and production, all supported by ISO 13485 certified cleanroom manufacturing facilities. The Brain Interchange System is a notable product, being a fully implantable, wireless device that allows for long-term sensing and adaptive stimulation of neural tissue. CorTec collaborates with academic researchers, clinicians, and industry partners involved in preclinical and clinical research globally. The company is recognized as a reliable partner for startups and established medical device companies looking to develop innovative neurotechnological therapies.

• Employees 65
• Founded 2010
• Total Funding $3270084